COPD: is it time to move away from corticosteriods?

FLAME is the first large-scale study comparing a LABA/LAMA with current standard of care (LABA/ICS) Salmeterol Fluticasone 50/500 in terms of reducing exacerbations in COPD patients with a history of exacerbations (one or more in the past year).